Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$160.67
5.053.25%
À la fermeture: -
$159.28
-1.39-0.87%
Après les heures de négociation: 4:07 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Lam Research Corp a un objectif de cours consensus de $141.8, basé sur les évaluations des 27 analystes. Le plus élevé est de $200 attribué par Susquehanna le octobre 23, 2025, et le plus bas est de $85 attribué par Bernstein le novembre 29, 2024. Les 3 dernières évaluations d'analystes ont été publiées par UBS, JP Morgan et Susquehanna le octobre 23, 2025. Avec un objectif de cours moyen de $176.67 entre UBS, JP Morgan et Susquehanna, il y a une variation implicite de 10.92% upside pour Lam Research Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
JP Morgan
Susquehanna
B. Riley Securities
TD Cowen
1calculé à partir des notes des analystes
Notes d'analystes pour Lam Research
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | 3.59% | UBS | $155 → $165 | Maintains | Buy | |||
10/23/2025 | 3.59% | JP Morgan | $113 → $165 | Maintains | Overweight | |||
10/23/2025 | 25.57% | Susquehanna | $135 → $200 | Maintains | Positive | |||
10/23/2025 | 13.01% | B. Riley Securities | $175 → $180 | Maintains | Buy | |||
10/23/2025 | 6.73% | TD Cowen | $145 → $170 | Maintains | Buy | |||
10/23/2025 | 0.45% | Stifel | $135 → $160 | Maintains | Buy | |||
10/23/2025 | -8.97% | Wells Fargo | $135 → $145 | Maintains | Equal-Weight | |||
10/23/2025 | 25.57% | Oppenheimer | $120 → $200 | Maintains | Outperform | |||
10/23/2025 | 6.73% | Mizuho | $162 → $170 | Maintains | Outperform | |||
10/23/2025 | -13.99% | Morgan Stanley | $125 → $137 | Maintains | Equal-Weight | |||
10/23/2025 | 9.87% | Citigroup | $120 → $175 | Maintains | Buy | |||
10/23/2025 | 0.45% | Needham | $150 → $160 | Maintains | Buy | |||
10/20/2025 | -10.85% | Barclays | $83 → $142 | Maintains | Equal-Weight | |||
10/16/2025 | 1.71% | Mizuho | $130 → $162 | Maintains | Outperform | |||
10/13/2025 | -15.24% | Stifel | $115 → $135 | Maintains | Buy | |||
10/09/2025 | 0.45% | Goldman Sachs | $115 → $160 | Maintains | Buy | |||
09/30/2025 | -20.27% | HSBC | → $127 | Initiates | → Hold | |||
09/29/2025 | -5.83% | Deutsche Bank | $100 → $150 | Upgrade | Hold → Buy | |||
09/24/2025 | 0.45% | B. Riley Securities | $130 → $160 | Maintains | Buy | |||
09/23/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
09/22/2025 | -21.52% | Morgan Stanley | $92 → $125 | Upgrade | Underweight → Equal-Weight | |||
09/12/2025 | -18.38% | Mizuho | $120 → $130 | Maintains | Outperform | |||
09/08/2025 | -24.66% | Citigroup | $113 → $120 | Maintains | Buy | |||
09/02/2025 | -42.24% | Morgan Stanley | $94 → $92 | Downgrade | Equal-Weight → Underweight | |||
08/21/2025 | -24.66% | Cantor Fitzgerald | $115 → $120 | Maintains | Overweight | |||
08/01/2025 | -29.06% | Citigroup | $108 → $113 | Maintains | Buy | |||
08/01/2025 | -24.66% | Argus Research | $105 → $120 | Maintains | Buy | |||
08/01/2025 | -24.66% | Mizuho | $115 → $120 | Maintains | Outperform | |||
07/31/2025 | -38.47% | Wells Fargo | $95 → $98 | Maintains | Equal-Weight | |||
07/31/2025 | -27.8% | Stifel | $110 → $115 | Maintains | Buy | |||
07/31/2025 | -40.98% | Morgan Stanley | $87 → $94 | Maintains | Equal-Weight | |||
07/31/2025 | -30.94% | Raymond James | $90 → $110 | Maintains | Outperform | |||
07/31/2025 | -24.66% | Oppenheimer | $110 → $120 | Maintains | Outperform | |||
07/31/2025 | -27.8% | Needham | $110 → $115 | Maintains | Buy | |||
07/29/2025 | -30.94% | Stifel | $92 → $110 | Maintains | Buy | |||
07/28/2025 | -47.89% | Barclays | $70 → $83 | Maintains | Equal-Weight | |||
07/21/2025 | -24.66% | UBS | $95 → $120 | Maintains | Buy | |||
07/15/2025 | -27.8% | Keybanc | $105 → $115 | Maintains | Overweight | |||
07/14/2025 | -27.8% | Mizuho | $100 → $115 | Maintains | Outperform | |||
07/10/2025 | -27.8% | Goldman Sachs | → $115 | Initiates | → Buy | |||
07/08/2025 | -40.36% | Wells Fargo | $75 → $95 | Maintains | Equal-Weight | |||
07/07/2025 | -32.19% | Citigroup | $87 → $108 | Maintains | Buy | |||
07/01/2025 | -45.38% | Morgan Stanley | $82 → $87 | Maintains | Equal-Weight | |||
06/24/2025 | -27.8% | Cantor Fitzgerald | $90 → $115 | Maintains | Overweight | |||
06/18/2025 | -27.8% | B. Riley Securities | $95 → $115 | Maintains | Buy | |||
06/17/2025 | -30.94% | Oppenheimer | $80 → $110 | Maintains | Outperform | |||
04/24/2025 | -40.36% | UBS | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -40.36% | JP Morgan | $110 → $95 | Maintains | Overweight | |||
04/24/2025 | -43.5% | Raymond James | $100 → $90 | Maintains | Outperform | |||
04/24/2025 | -56.05% | Deutsche Bank | $78 → $70 | Maintains | Hold | |||
04/24/2025 | -40.36% | B. Riley Securities | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -49.77% | Needham | $96 → $80 | Maintains | Buy | |||
04/24/2025 | -48.52% | Morgan Stanley | $81 → $82 | Maintains | Equal-Weight | |||
04/24/2025 | -43.5% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
04/24/2025 | -37.22% | TD Securities | $110 → $100 | Maintains | Buy | |||
04/24/2025 | -52.91% | Wells Fargo | $85 → $75 | Maintains | Equal-Weight | |||
04/24/2025 | -37.85% | Evercore ISI Group | $95 → $99 | Maintains | Outperform | |||
04/22/2025 | -56.05% | Barclays | $75 → $70 | Maintains | Equal-Weight | |||
04/16/2025 | -43.5% | B of A Securities | $110 → $90 | Maintains | Buy | |||
04/15/2025 | -42.24% | Stifel | $100 → $92 | Maintains | Buy | |||
04/14/2025 | -43.5% | UBS | $95 → $90 | Maintains | Buy | |||
04/11/2025 | -49.77% | Oppenheimer | $95 → $80 | Maintains | Outperform | |||
03/28/2025 | -37.22% | Jefferies | $95 → $100 | Maintains | Buy | |||
03/20/2025 | -40.36% | Oppenheimer | → $95 | Initiates | → Outperform | |||
02/20/2025 | -34.08% | Keybanc | $95 → $105 | Maintains | Overweight | |||
02/20/2025 | -30.94% | B of A Securities | $100 → $110 | Maintains | Buy | |||
02/20/2025 | -21.52% | Susquehanna | $75 → $125 | Upgrade | Neutral → Positive | |||
02/20/2025 | -37.22% | Mizuho | $87 → $100 | Maintains | Outperform | |||
02/20/2025 | -37.22% | Cantor Fitzgerald | $100 → $100 | Reiterates | Overweight → Overweight | |||
02/18/2025 | -37.22% | Cantor Fitzgerald | $100 → $100 | Maintains | Overweight | |||
01/31/2025 | -51.03% | Deutsche Bank | $76 → $78 | Maintains | Hold | |||
01/30/2025 | -49.15% | Morgan Stanley | $78 → $81 | Maintains | Equal-Weight | |||
01/30/2025 | -45.38% | Mizuho | $90 → $87 | Maintains | Outperform | |||
01/30/2025 | -37.22% | Cantor Fitzgerald | $95 → $100 | Upgrade | Neutral → Overweight | |||
01/30/2025 | -46.63% | Wells Fargo | $82 → $85 | Maintains | Equal-Weight | |||
01/30/2025 | -43.5% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
01/17/2025 | -40.36% | Keybanc | $95 → $95 | Upgrade | Sector Weight → Overweight | |||
01/17/2025 | -52.91% | Barclays | $90 → $75 | Maintains | Equal-Weight | |||
01/15/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
01/13/2025 | -43.5% | Needham | $100 → $90 | Maintains | Buy | |||
01/13/2025 | -48.52% | Wells Fargo | $83 → $82 | Maintains | Equal-Weight | |||
01/10/2025 | -43.5% | Mizuho | $95 → $90 | Maintains | Outperform | |||
01/10/2025 | -46.63% | Goldman Sachs | $96 → $85 | Maintains | Buy | |||
12/06/2024 | -47.89% | Wells Fargo | $85 → $83 | Maintains | Equal-Weight | |||
12/05/2024 | -51.03% | Morgan Stanley | $76 → $78 | Maintains | Equal-Weight | |||
11/29/2024 | -46.63% | Bernstein | $95 → $85 | Maintains | Market Perform | |||
10/24/2024 | -37.22% | Cantor Fitzgerald | $100 → $100 | Reiterates | Neutral → Neutral | |||
10/24/2024 | -52.29% | Morgan Stanley | $77 → $76 | Maintains | Equal-Weight | |||
10/24/2024 | -37.22% | Stifel | $105 → $100 | Reiterates | Buy → Buy | |||
10/24/2024 | -46.63% | Wells Fargo | $88 → $85 | Maintains | Equal-Weight | |||
10/24/2024 | -30.94% | B. Riley Securities | $105 → $110 | Reiterates | Buy → Buy | |||
10/24/2024 | -37.22% | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
10/03/2024 | 452.49% | Wells Fargo | $1000 → $880 | Maintains | Equal-Weight | |||
09/30/2024 | 527.83% | Cantor Fitzgerald | $1200 → $1000 | Maintains | Neutral | |||
09/20/2024 | 496.43% | Mizuho | $1050 → $950 | Maintains | Outperform | |||
09/17/2024 | 385.94% | Morgan Stanley | $929 → $774 | Maintains | Equal-Weight | |||
09/16/2024 | 460.65% | Citigroup | $990 → $893 | Maintains | Buy | |||
09/12/2024 | 622% | UBS | $1250 → $1150 | Maintains | Buy | |||
08/05/2024 | 521.55% | Citigroup | $1025 → $990 | Maintains | Buy | |||
08/01/2024 | 559.22% | Mizuho | $960 → $1050 | Maintains | Outperform |
FAQ
Quel est le cours indicatif de l'action Lam Research (LRCX) ?
Le dernier objectif de prix pour Lam Research (NASDAQ:LRCX) a été rapporté par UBS le octobre 23, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $165.00 s'attendant à ce que LRCX se rise dans les 12 prochains mois (un possible changement de 3.59% upside). 86 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Lam Research (LRCX) ?
La dernière note d'analyste pour Lam Research (NASDAQ:LRCX) a été fournie par UBS, et Lam Research maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Lam Research (LRCX) ?
La dernière amélioration pour Lam Research Corp a eu lieu le septembre 29, 2025 lorsque Deutsche Bank a augmenté leur objectif de prix à $150. Deutsche Bank avait précédemment a hold pour Lam Research Corp.
Quand a eu lieu la dernière dégradation pour Lam Research (LRCX) ?
La dernière réduction pour Lam Research Corp a eu lieu le septembre 23, 2025 lorsque Keybanc a changé leur objectif de prix de N/A à N/A pour Lam Research Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Lam Research (LRCX) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Lam Research, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Lam Research a été déposée le octobre 23, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 23, 2026.
La note d'analyste pour Lam Research (LRCX) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Lam Research (LRCX) était un maintenu avec un objectif de prix de $155.00 à $165.00. Le prix actuel de Lam Research (LRCX) est de $159.28, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.